Inhalable inhibitors of inflammation in the respiratory tract

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S452000, C514S453000, C514S456000, C514S460000, C514S475000

Reexamination Certificate

active

07012091

ABSTRACT:
Sesquiterpene epoxide compounds (trichothecenes) and methods for administering such compounds by inhalation to inhibit inflammatory responses in the respiratory tract are disclosed.

REFERENCES:
patent: 4744981 (1988-05-01), Pavanasasivam
patent: 4906452 (1990-03-01), Sivam
patent: 6323219 (2001-11-01), Costanzo
patent: 6342520 (2002-01-01), Zamoyski
patent: 6346251 (2002-02-01), Zamoyski
patent: 6355251 (2002-03-01), Zamoyski
patent: 6559178 (2003-05-01), Zamoyski
patent: 6576812 (2003-06-01), Longley
REGISTRY,“trichothecene,” Jun. 23, 2005.
BIOSIS AN 2000:512309, Albarenque, S et al, Exper Toxic Path, Aug. 2000, 52 (4) 297-301, abstract.
MEDLINE AN 83218051, Pruet C et al, Laryngoscope, Jun. 1983, 93 (6) 749-55, abstract.
MEDLINE AN 2000392736, Pemberton A et al, Clin exper allergy, Jun. 2000, 30 (6) 818-32, abstract.
Okazaki et. al., “Antiviral Activity of Macrocyclic Trichothecene Mycotoxins . . . ” Agricultural and Biological Chemistry, 1989, vol. 53 pp. 1441-1443.
Okazaki et. al., “Inhibition by Trichothecene Mycotoxins of Replication of Herpes Simplex Virus Type 2”, Agricultural and Biological Chemistry, 1988, vol. 52 pp. 795-801.
Dearborn et. al., Morbidity and Mortality Weekly Report, Dec. 9, 1994, vol. 43, No. 48, pp. 881-883.
U. S. Amrid, “Understanding the Threat”, website printout on Aug. 27, 1999, 7 pages.
Fauci et. al., Harrison's Principles of Internal Medicine, 14th edition, McGraw Hill, 1998 , pp. 528, 1423-1425.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhalable inhibitors of inflammation in the respiratory tract does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhalable inhibitors of inflammation in the respiratory tract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhalable inhibitors of inflammation in the respiratory tract will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3587042

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.